Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

flaxseed and Reduced Low-Density Lipoprotein Level

Research synthesisModerate evidenceSmall effect5 studies · 3 beneficial · 2 neutral · 0 harmful

Across 5 studies, 3 reported beneficial effects of flaxseed supplementation on reducing low-density lipoprotein (LDL) cholesterol, with effect sizes ranging from small to moderate. The median study duration was 70 days, suggesting effects typically observed at 8-12 weeks. The most studied population includes clinical groups such as patients with type 2 diabetes, postmenopausal women, and those with dyslipidemia, though doses varied and were not consistently reported.

  • Effective dose range: 28-30 g/day
  • Studied populations: patients with type 2 diabetes, postmenopausal women, patients with dyslipidemia

Caveats: Available evidence is overwhelmingly positive — clinical literature in this area is subject to publication bias (null-result studies are less likely to be published or indexed). Many of the included studies did not reach statistical significance — effect may be smaller than the predominant direction suggests. The highest-quality study (evidence score 7) found a neutral effect, which tempers confidence in the overall benefit.

Generated Jul 11, 2026
Doses used in studies
  • g/day: 28–30 (median 29, IQR 28.529.5) 2 studies
Time to effect
Median: 10 weeks · IQR 10 weeks10 weeks · Range 10 weeks10 weeks — Reported in 1 of 5 studies
5 of 5 papers
Back to top